Literature DB >> 31651345

Correction to: Transcriptional factor six2 promotes the competitive endogenous RNA network between CYP4Z1 and pseudogene CYP4Z2P responsible for maintaining the stemness of breast cancer cells.

Lufeng Zheng1, Qianqian Guo1, Chenxi Xiang2, Shijia Liu3, Yuzhang Jiang4, Lanlan Gao1, Haiwei Ni1, Ting Wang1, Qiong Zhao1, Hai Liu1, Yingying Xing1, Yaohui Wang5, Xiaoman Li6, Tao Xi7.   

Abstract

The original article [1] contained an error in Fig. 7c whereby the same flow image was accidentally misused for the second and fourth group.

Entities:  

Year:  2019        PMID: 31651345      PMCID: PMC6814126          DOI: 10.1186/s13045-019-0809-3

Source DB:  PubMed          Journal:  J Hematol Oncol        ISSN: 1756-8722            Impact factor:   17.388


Correction to: J Hematol Oncol (2019) 12:23 https://doi.org/10.1186/s13045-019-0697-6 The original article [1] contained an error in Fig. 7c whereby the same flow image was accidentally misused for the second and fourth group. The correct version of Fig. 7c can be viewed below together with the rest of Fig. 7.
Fig. 7

CeRNET_CC is sufficient and necessary for six2-induced effects. a, b Phase contrast images of mammospheres formed by MCF-7-six2 cells with si-CYP4Z1 or si-CYP4Z2P treatment (a) and quantification of spheres (b). The data are presented as the means ± SDs, n = 3, *P < 0.05, **P < 0.01 vs. MCF-7-six2. c Representative FACS profile of cells described in a with CD24− and CD44+ markers. d, e Cells depicted in a were subjected to western blot analysis and followed by detecting the expression of p-Akt/p-ERK1/2 (e) and stemness markers (ALDH1 and OCT3/4) (d). f Images of tumors harvested when MCF-7, MCF-7-six2, MCF-7-six2-si-Z1, and MCF-7-six2-si-Z2P cells (left) and MCF-7-Plko-six2, MCF-7-Plko-six2-Z1-UTR, and MCF-7-Plko-six2-Z2P-UTR cells (right) were planted

CeRNET_CC is sufficient and necessary for six2-induced effects. a, b Phase contrast images of mammospheres formed by MCF-7-six2 cells with si-CYP4Z1 or si-CYP4Z2P treatment (a) and quantification of spheres (b). The data are presented as the means ± SDs, n = 3, *P < 0.05, **P < 0.01 vs. MCF-7-six2. c Representative FACS profile of cells described in a with CD24− and CD44+ markers. d, e Cells depicted in a were subjected to western blot analysis and followed by detecting the expression of p-Akt/p-ERK1/2 (e) and stemness markers (ALDH1 and OCT3/4) (d). f Images of tumors harvested when MCF-7, MCF-7-six2, MCF-7-six2-si-Z1, and MCF-7-six2-si-Z2P cells (left) and MCF-7-Plko-six2, MCF-7-Plko-six2-Z1-UTR, and MCF-7-Plko-six2-Z2P-UTR cells (right) were planted
  1 in total

1.  Transcriptional factor six2 promotes the competitive endogenous RNA network between CYP4Z1 and pseudogene CYP4Z2P responsible for maintaining the stemness of breast cancer cells.

Authors:  Lufeng Zheng; Qianqian Guo; Chenxi Xiang; Shijia Liu; Yuzhang Jiang; Lanlan Gao; Haiwei Ni; Ting Wang; Qiong Zhao; Hai Liu; Yingying Xing; Yaohui Wang; Xiaoman Li; Tao Xi
Journal:  J Hematol Oncol       Date:  2019-03-04       Impact factor: 17.388

  1 in total
  1 in total

1.  ARID1A deficiency weakens BRG1-RAD21 interaction that jeopardizes chromatin compactness and drives liver cancer cell metastasis.

Authors:  Xue-Ying Shang; Yi Shi; Dan-Dan He; Lan Wang; Qing Luo; Chuan-Huai Deng; Yu-Lan Qu; Na Wang; Ze-Guang Han
Journal:  Cell Death Dis       Date:  2021-10-23       Impact factor: 8.469

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.